Bhubaneswar: About 20 per cent of people in Odisha have not developed antibodies despite taking two doses of COVID vaccines.
Life Sciences (ILS) director Ajay Parida told the media on Saturday that this has come to light following genome sequencing by the institute.
He said the ILS here had conducted genome sequencing of 600 samples in August this year and identified 425 Delta variants and other variants of COVID-19. However, no new mutation was found.
He further said as genome sequencing has revealed that 20 per cent of people have not developed antibodies against COVID-19 despite taking two doses of vaccines, a study is underway to determine whether a third dose or a booster dose is required.
If there is a requirement, it will be studied whether the people would be given the vaccines of the same company they had taken earlier or they need the vaccines of other companies.
Bhubaneswar: External Affairs Minister S Jaishankar and BJP's national president JP Nadda will attend party…
Bhubaneswar: Odisha's chief electoral officer (CEO) has ordered transfer of IIC and a sub-inspector of…
New Delhi: There will be more than a fortnight’s wait for results of Central Board of…
New Delhi: After days of suspense and speculation, we finally came to know on deadline…
Bhubaneswar: The Odisha government on Friday removed IAS officer Sujata Karthikeyan from the post of…
New Delhi: An Indian couple visiting Canada and their 3-month-old grandson lost their lives as…
Bhubaneswar: Putting rest to speculations about his participation in the ensuing elections, Khandapada MLA Soumya…
Bhubaneswar: Tata Steel Special Economic Zone Limited (TSSEZL) and HHP Five Private Limited (Hygenco) have…